Evelo Biosciences CEO Balkrishan Gill's 2018 pay jumps 144% to $4.5M
Evelo Biosciences reports 2018 executive compensation
By ExecPay News
Published: April 25, 2019
Evelo Biosciences reported fiscal year 2018 executive compensation information on April 25, 2019.
In 2018, three executives at Evelo Biosciences received on average a compensation package of $3.3M, a 144% increase compared to previous year.
Average pay of disclosed executives at Evelo Biosciences
Balkrishan Simba Gill, Chief Executive Officer, received $4.5M in total, which increased by 144% compared to 2017. 82% of Gill's compensation, or $3.7M, was in option awards. Gill also received $300K in non-equity incentive plan and $492K in salary.
Jonathan Poole, Chief Financial Officer, received a compensation package of $3M. 82% of the compensation package, or $2.5M, was in option awards.
Duncan McHale, M.B.B.S., Chief Medical Officer, earned $2.3M in 2018, a 171% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 25, 2019.